Search Results 2051-2060 of 14728 for anti-TNF drugs

  1. Triamcinolone (Intra-Articular Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Brimonidine And Brinzolamide (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Simbrinza. Descriptions. Brimonidine and brinzolamide ...

  3. Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Emtricitabine And Tenofovir (Oral Route) Description and Brand Names - Mayo Clinic

    Emtricitabine and tenofovir disoproxil fumarate combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...

  5. Rotigotine (Transdermal Route) Before Using - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

  6. Trastuzumab-Anns (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Upadacitinib (Oral Route) Precautions - Mayo Clinic

    Use an effective form of birth control to keep from getting pregnant during treatment and for at least 4 weeks after the last dose. If you think you have become ...

  8. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    Past use of any anti-interleukin (IL)-13 or anti-IL-14/IL-13 therapy, including lebrikizumab; Evidence of acute or chronic hepatitis or known liver cirrhosis.

  9. Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now - Mayo Clinic

    The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...

  10. Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression (ADVANCE Trial) - Mayo Clinic

    About this study. The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems ...